Genexine, Inc. (095700.KQ)
KRW 5590.0
(-3.79%)
KRW 5590.0
(-3.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.42 Billion | 16.13 Billion | 36.82 Billion | 18.54 Billion | 11.3 Billion | 12.88 Billion |
| Cost of Revenue | 4.03 Billion | 8.83 Billion | 7.67 Billion | 8.99 Billion | 5.74 Billion | 8.6 Billion |
| Gross Profit | 387.48 Million | 7.3 Billion | 29.15 Billion | 9.55 Billion | 5.56 Billion | 4.27 Billion |
| Operating Expenses | 41.62 Billion | 41.71 Billion | 54.62 Billion | 53.21 Billion | 52.18 Billion | 47.03 Billion |
| Selling, General and Administrative Expenses | 7.24 Billion | 17 Billion | 16.23 Billion | 9.91 Billion | 9.9 Billion | 10.14 Billion |
| Research and Development Expenses | 26.33 Billion | 24.71 Billion | 38.38 Billion | 42.59 Billion | 41.46 Billion | 35.82 Billion |
| Other Expenses | 8.05 Billion | 1.91 Billion | 1.98 Billion | -706.48 Million | -809.36 Million | -1.06 Billion |
| Cost and Expenses | 45.66 Billion | 50.55 Billion | 62.3 Billion | 62.2 Billion | 57.92 Billion | 55.64 Billion |
| Operating Income | -41.24 Billion | -34.41 Billion | -25.47 Billion | -43.66 Billion | -46.61 Billion | -42.76 Billion |
| Interest Expense | 4.11 Billion | 3.32 Billion | 2.28 Billion | 3.81 Billion | 4.58 Billion | 2.66 Billion |
| Income Tax Expense | 16.84 Billion | -857.24 Million | -834.47 Million | -33.82 Million | 16.13 Billion | - |
| Earnings before Tax | -50.02 Billion | -7 Billion | -27.08 Billion | 42.28 Billion | -371.59 Million | -34.06 Billion |
| Net Income | -66.87 Billion | -56.27 Billion | -47.72 Billion | 27.56 Billion | -16.5 Billion | -34.06 Billion |
| Earnings Per Share Basic | -1652.14 | -1326.23 | -1375.57 | 825.46 | -556.06 | -1203.58 |
| Earnings Per Share Diluted | -1652.14 | -1326.23 | -1375.57 | 627.18 | -556.06 | -1203.58 |
| Weighted Average Shares Outstanding | 40.47 Million | 42.43 Million | 34.69 Million | 33.39 Million | 29.68 Million | 28.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 40.47 Million | 42.43 Million | 34.69 Million | 33.96 Million | 29.68 Million | 28.3 Million |
| Gross Margin | 0.09 | 0.45 | 0.79 | 0.52 | 0.49 | 0.33 |
| EBIT Margin | -9.23 | -1.83 | -0.60 | -2.20 | -3.92 | -3.14 |
| Profit Margin | -15.11 | -3.49 | -1.30 | 1.49 | -1.46 | -2.64 |
| EBITDA | -40.87 Billion | -29.54 Billion | -22.17 Billion | 47.99 Billion | 6.56 Billion | -29.11 Billion |
| Earnings Before Tax Margin | -9.32 | -2.13 | -0.69 | -2.35 | -4.12 | -3.32 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 344.49 Million | 2.07 Billion | 1.53 Billion | 4.42 Billion | 368.51 Million | 1.83 Billion |
| Cost of Revenue | 1.67 Billion | 3.48 Billion | 2.44 Billion | 8.42 Billion | 1.61 Billion | 2.72 Billion |
| Gross Profit | -1.33 Billion | -1.41 Billion | -915.29 Million | -3.99 Billion | -1.24 Billion | -889.27 Million |
| Operating Expenses | 5.36 Billion | 11.23 Billion | 1.82 Billion | 37.93 Billion | 14.55 Billion | 11.1 Billion |
| Selling, General and Administrative Expenses | 2.25 Billion | 4.1 Billion | 547.15 Million | - | 7.07 Billion | 3.28 Billion |
| Research and Development Expenses | 3.1 Billion | 7.13 Billion | 1.27 Billion | - | 7.48 Billion | 7.81 Billion |
| Other Expenses | -6.51 Billion | 278.48 Million | -9.61 Billion | -316.5 Million | -679.58 Million | 149.89 Million |
| Cost and Expenses | 7.04 Billion | 14.72 Billion | 4.27 Billion | 46.35 Billion | 16.17 Billion | 13.82 Billion |
| Operating Income | -6.69 Billion | -12.64 Billion | -2.74 Billion | -41.92 Billion | -15.8 Billion | -11.99 Billion |
| Interest Expense | 764.64 Million | 727.72 Million | 1.35 Billion | 4.18 Billion | 889.61 Million | 970.86 Million |
| Income Tax Expense | 14.55 Million | -307.54 Million | -16.91 Billion | 16.85 Billion | 4.88 Billion | 49.48 Million |
| Earnings before Tax | -6.33 Billion | -11.87 Billion | -14.32 Billion | -50.02 Billion | -16.05 Billion | -11.77 Billion |
| Net Income | -12.09 Billion | -11.56 Billion | 2.58 Billion | -66.87 Billion | -20.93 Billion | -24.61 Billion |
| Earnings Per Share Basic | -291.69 | -279.03 | 62.48 | - | -505.07 | -603.06 |
| Earnings Per Share Diluted | -291.69 | -279.03 | 62.48 | - | -505.07 | -603.06 |
| Weighted Average Shares Outstanding | 41.44 Million | 41.44 Million | 41.44 Million | 40.47 Million | 41.44 Million | 40.81 Million |
| Weighted Average Shares Outstanding (Diluted) | 41.44 Million | 41.44 Million | 41.44 Million | 40.47 Million | 41.44 Million | 40.81 Million |
| Gross Margin | -3.87 | -0.68 | -0.60 | -0.90 | -3.39 | -0.49 |
| EBIT Margin | -15.94 | -5.49 | -0.93 | - | -39.56 | -5.87 |
| Profit Margin | -35.10 | -5.58 | 1.69 | -15.11 | -56.81 | -13.44 |
| EBITDA | -5.49 Billion | -11.38 Billion | -1.42 Billion | - | -14.57 Billion | -10.75 Billion |
| Earnings Before Tax Margin | -19.45 | -6.10 | -1.79 | -9.47 | -42.89 | -6.55 |
KEEPLEARN
PF
OMF
301131
DNA2
CPN